InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-3.2%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Vizirgianakis Stavros G., Chairman & CEO. Officer active across 4 companies, notably MISONIX INC. Cumulatively, 10 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €1.1m. History available since 16 June 2022. The latest transaction was filed on 15 August 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
450,000 sharesRestricted Stock UnitsSEC:0001493152-26-028771:0
243,243 shares0Common StockSEC:0001235802-24-000071:0
217,770 shares0Common StockSEC:0001235802-23-000094:0
144,639 shares0Common Stock, $0.000001 par valueSEC:0001235802-22-000122:0
2,264,861 shares@ US$0.48100.0% of flowCommon Stock, $0.000001 par valueSEC:0001235802-22-000113:0
Ideal exit: 4 Jul 2023 (T+270)
70,776 shares0Common Stock, $0.000001 par valueSEC:0001235802-22-000107:0
965 shares0Class A common stockSEC:0000899243-22-023647:0
2,780,923 sharesClass A Common StockSEC:0000899243-22-015851:0
2,136,478 sharesCommon StockSEC:0001493152-21-030853:0
2,136,478 sharesCommon StockSEC:0001493152-21-030853
10 of 10 declarations
About Vizirgianakis Stavros G.
Stavros G. Vizirgianakis is the Chairman and CEO of MISONIX Inc. and Bioventus Inc. He oversees the strategic operations and business development of both companies, focusing on innovation in the medical device sector. Vizirgianakis is recognized for his leadership and ability to guide teams toward achieving growth objectives.
